Shares of health-care companies rose on deal speculation.
Cancer-treatment developer Juno Therapeutics shares surged after reports it was in deal talks with larger biotech company Celgene.
Continue Reading Below
Exelixis, another oncology-focused biotech, said a liver-cancer therapy showed promise in a clinical trial.
Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
January 17, 2018 17:16 ET (22:16 GMT)